Background illustration for clinical trials search

Paid Clinical Trials Wilmington

Discover 162 paid clinical trials in Wilmington, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Wilmington NC, Summerville SC, Asheville NC,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase 2, Recruiting

SUNOSI® (Solriamfetol) Pregnancy Registry

for
Narcolepsy, Obstructive Sleep Apnea,
Location: Wilmington NC, Morrisville NC
Sponsor: Axsome Therapeutics, Inc.

Sex: Female

Age: 0+

Code: NCT06413420

Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Wilmington NC, Durham NC, Greensboro NC, Charlotte NC,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase 2, Recruiting

Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

for
Migraine
Location: Wilmington NC
Sponsor: Pfizer

Sex: Female

Age: 0+

Code: NCT05046613

Recruiting

IBD Pregnancy Registry

for
Inflammatory Bowel Disease (IBD)
Location: Wilmington NC
Sponsor: CorEvitas

Sex: Female

Age: 18 - 50

Code: NCT06910553

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Wilmington NC, Pinehurst NC, Durham NC, Fort Mill SC,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial Lines

for
Upper Facial Lines, Glabellar Lines
Location: Wilmington NC, Arlington VA, Washington D.C. DC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07871513

Phase 2, Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Wilmington NC, Cary NC, Savannah GA, Greenville SC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting
New

Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)

for
Growth
Location: Wilmington NC, Jacksonville FL, Harbor Beach FL,
Sponsor: Mead Johnson Nutrition

Sex: All

Age: 0

Code: NCT07513506

Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Wilmington NC, Morehead City NC, Greenville NC,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase 3, Recruiting

Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)

for
Long QT Syndrome (LQTS) 2
Location: Wilmington NC, Boston MA, Chicago IL, Rochester MN,
Sponsor: Thryv Therapeutics, Inc.

Sex: All

Age: 15+

Code: NCT07277582

Phase 2, Phase 3, Recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

for
Pneumococcal Disease
Location: Wilmington NC, Durham NC, Summerville SC, Matthews NC,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07629440

Phase 3, Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Wilmington NC, Greenville NC, Norfolk VA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase 2, Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Wilmington NC, Winston-Salem NC, Richmond VA,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

for
Heart Failure
Location: Wilmington NC, Pinehurst NC, Statesville NC, Lenoir NC,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06935370

Phase 3, Recruiting

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

for
Schizophrenia
Location: Rose Hill NC, Kinston NC, Fort Mill SC, Baltimore MD,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07101094

Recruiting

ALTO-100 in Bipolar Disorder With Depression (BD-D)

for
Bipolar Disorder I or II With a Major Depressive Episode
Location: Rose Hill NC, Cary NC, Fairfax VA, Gaithersburg MD,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT06656416

Phase 2, Recruiting

Study of ALTO-300 in MDD

for
Major Depressive Disorder
Location: Rose Hill NC, Winston-Salem NC, Fairfax VA,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT05922878

Phase 2, Recruiting

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

for
Hypercholesterolaemia
Location: Little River SC, Monroe NC, Richmond VA, Manassas VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07610278

Phase 2, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Savannah GA, Washington D.C. DC, Millville DE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting